Krempa David bought ETON
October 2, 2026 · Form 4 insider transaction
Krempa David bought 10,522 shares of Eton Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,522
Price
N/A
Total value
N/A
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 2, 2026
Filing dateOctober 6, 2026
Shares owned after47,547
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On October 2, 2024, the reporting person was granted 42,088 restricted stock units which vest in four equal annual installments beginning October 2, 2025.